Clinical resequencing of a high‐risk cancer susceptibility gene such as BRCA1 (MIM #113705) or BRCA2 (MIM #600185) may reveal that a patient carries a clearly pathogenic sequence variant. This evidence concerns the gene BRCA1 and cancer.